Concepedia

Thomas Voshaar

TV

Statistics

Publications

10

Citations

1.3K

H-Index

10

Active since

2002

Affiliations

Krankenhaus Bethanien(Current)

Fachkrankenhaus Kloster Grafschaft

Philipps University of Marburg

University Medical Center Hamburg-Eppendorf

Klinik Donaustauf

Thomas Voshaar is an author at Krankenhaus Bethanien specializing in pharmacy, pulmonology, and respiratory disease.

Publications per year

2002–2021

10

Publications

10

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study

Christian Karagiannidis, Carina Mostert, Corinna Hentschker et al. · The Lancet Respiratory Medicine · 2020 · 864 citations · Full text

, , +16

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19

Santiago Ewig, Thomas Voshaar, Winfried Randerath et al. · Respiration · 2020 · 85 citations · Full text

, , +15

Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium

Paul Colthorpe, Thomas Voshaar, Thomas Kieckbusch et al. · Journal of Drug Assessment · 2013 · 73 citations · Full text

, , +17

A randomized study of tiotropium Respimat® Soft MistTM Inhaler vs. ipratropium pMDI in COPD

Thomas Voshaar, Robert J. Lapidus, R. Maleki-Yazdi et al. · Respiratory Medicine · 2007 · 57 citations · Full text

, , +11

Comparing Usability of NEXThaler <sup>®</sup> with Other Inhaled Corticosteroid/Long-Acting β <sub>2</sub> -Agonist Fixed Combination Dry Powder Inhalers in Asthma Patients

Thomas Voshaar, Monica Spinola, Patrick G. Linnane et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2013 · 56 citations · Full text

, , +17

1–5 of 10